Terms: = Prostate cancer AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Clinical Outcome
4 results:
1. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer.
Ding Y; Li N; Dong B; Guo W; Wei H; Chen Q; Yuan H; Han Y; Chang H; Kan S; Wang X; Pan Q; Wu P; Peng C; Qiu T; Li Q; Gao D; Xue W; Qin J
J Clin Invest; 2019 Feb; 129(2):759-773. PubMed ID: 30496141
[TBL] [Abstract] [Full Text] [Related]
2. Active surveillance for low-risk prostate cancer.
Klotz L
Curr Opin Urol; 2017 May; 27(3):225-230. PubMed ID: 28267056
[TBL] [Abstract] [Full Text] [Related]
3. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
Bonkhoff H; Wheeler TM; van der Kwast TH; Magi-Galluzzi C; Montironi R; Cohen RJ
Prostate; 2013 Mar; 73(4):442-8. PubMed ID: 22949099
[TBL] [Abstract] [Full Text] [Related]
4. Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis.
Bologna M; Vicentini C; Festuccia C; Muzi P; Napolitano T; Biordi L; Miano L
Eur Urol; 1988; 15(3-4):243-7. PubMed ID: 3215259
[TBL] [Abstract] [Full Text] [Related]
